MC
MDT icon

Moors & Cabot’s Medtronic MDT Stock Holding History

Moors & Cabot’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-300
Closed -$1K – 669
2019
Q3 		$1K Buy
+300
New +$31.3K ﹤0.01% 669

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Moors & Cabot's MDT Position: Q1 2026 in Review

Moors & Cabot increased its Medtronic (MDT) stake by 12% in Q1 2026, buying an estimated $622K and bringing the position to 61,225 shares worth $5.31M. The position accounts for 0.23% of the portfolio, ranked #94.

Moors & Cabot first reported a position in MDT in Q1 2014 and has held it in 49 quarters since. The position peaked at $7.47M in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Moors & Cabot held 61,225 shares of Medtronic worth $5.31M as of Q1 2026.
  • Moors & Cabot bought 6,494 Medtronic shares in Q1 2026, an estimated $622K.
  • Medtronic made up 0.23% of Moors & Cabot's portfolio in Q1 2026, its #94 holding.
  • Moors & Cabot first reported a position in Medtronic in Q1 2014 and has held it in 49 quarters since.
  • Moors & Cabot's Medtronic position peaked at $7.47M in Q1 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.